Kalle Sigfridsson

5PUBLICATIONS
10CO-AUTHORS
Pharmaceutical delivery technologiesCharacterisation of biological macromoleculesPowder and particle technologyPhysical properties of materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 07, 2026
Amorphous particles enhance oral exposure-a case study of a poorly soluble compound in preclinical, toxicology and early clinical studies.

|Feb 20, 2026
Self-Assembly of a Therapeutic Peptide Surfactant: A Small-Angle X-ray Scattering Study.

Ellen Brunzell, Kalle Sigfridsson, L Magnus Bergström

|Sep 14, 2024
Pharmacokinetics of nano- and microcrystal formulations of low solubility compounds after intramuscular injection to mice.

Krishna C Aluri, Kalle Sigfridsson, Aixiang Xue

|Jul 24, 2024
Case study: cremophor EL-based liquid formulations as simple substitutes for amorphous solid dispersions in early preclinical in vivo studies.

Kalle Sigfridsson, Xiang Zhang, Antonio Llinas

|Dec 13, 2023
The In Vivo Fate of Polycatecholamine Coated Nanoparticles Is Determined by a Fibrinogen Enriched Protein Corona.

Gustav Emilsson, Kai Liu, Fredrik Höök

Pageof 1

Frequent Collaborators

1 joint publications

Gustav Emilsson

1 joint publications

Kai Liu

1 joint publications

Fredrik Höök

1 joint publications

Lennart Lindfors